EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Immunohistochemical Analysis of MUC1 and MUC4 Co-expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Mohammed Abidullah

Annals of African Medicine · 2026

DOI: 10.4103/aam.aam_235_25 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Mohammed Abidullah. Beteiligte Einrichtung: Department of Biomedical Dental Sciences, Faculty of Dentistry, Al Baha University, Al Baha, Saudi Arabia. Hauptthemen laut MEDLINE: Mucin-1, Leukoplakia, Oral, Mucin-4, Mouth Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This study aimed to evaluate the immunohistochemical co-expression of MUC1 and MUC4 in oral leukoplakia (OL) and oral squamous cell carcinoma (OSCC) and assess their potential as biomarkers for diagnosing and prognosticating oral malignancies. Materials and Methods: A retrospective observational study was conducted on formalin-fixed, paraffin-embedded tissue specimens from the archives of the Department of Oral Pathology and Microbiology. A total of 80 histopathologically confirmed cases, consisting of 40 OL and 40 OSCC cases, were selected. Immunohistochemical staining for MUC1 and MUC4 was performed using specific monoclonal antibodies, and the expression was evaluated based on localization, intensity, and extent of staining. Statistical analysis was performed using SPSS, with P < 0.05 considered statistically significant.

Results

The study found that MUC1 and MUC4 expression were significantly higher in OSCC compared to OL. High MUC1 expression was observed in 82.5% of OSCC cases versus 30% in OL cases ( P < 0.001), and high MUC4 expression was found in 70% of OSCC cases versus 30% in OL ( P = 0.002). Co-expression of MUC1 and MUC4 was seen in 90% of OSCC cases and 65% of OL cases ( P = 0.027). Logistic regression analysis confirmed that OSCC diagnosis was a strong predictor of high MUC1 and MUC4 expression ( P < 0.001).

Conclusion

The findings suggest that MUC1 and MUC4 are significantly overexpressed in OSCC compared to OL, and their co-expression may serve as a valuable biomarker combination for early diagnosis and prognosis. Elevated expression of both mucins is associated with poor prognosis, indicating their potential for use in clinical practice for risk stratification and personalized treatment in OSCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucin-1Leukoplakia, OralMucin-4Mouth NeoplasmsCarcinoma, Squamous CellHumansImmunohistochemistryRetrospective StudiesFemaleMaleBiomarkers, TumorMiddle AgedAdultAgedPrognosis

Stichwörter der Autor:innen

ImmunohistochemistryImmunohistochimieMUC1MUC4carcinome épidermoïde oralleucoplasie oraleoral leukoplakiaoral squamous cell carcinoma

Substanzen

Mucin-1Mucin-4Biomarkers, TumorMUC4 protein, humanMUC1 protein, human

Autor:innen und Institutionen

  • Department of Biomedical Dental Sciences, Faculty of Dentistry, Al Baha University, Al Baha, Saudi Arabia.

Zitieren

APA

Abidullah, M. (2026). Immunohistochemical Analysis of MUC1 and MUC4 Co-expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Annals of African Medicine. https://doi.org/10.4103/aam.aam_235_25

Vancouver

Abidullah M. Immunohistochemical Analysis of MUC1 and MUC4 Co-expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Annals of African Medicine. 2026. doi:10.4103/aam.aam_235_25

BibTeX
@article{Abidullah2026,
  author = {Abidullah, Mohammed},
  title = {Immunohistochemical Analysis of MUC1 and MUC4 Co-expression in Oral Leukoplakia and Oral Squamous Cell Carcinoma},
  journal = {Annals of African Medicine},
  year = {2026},
  doi = {10.4103/aam.aam_235_25}
}
Kostenlos starten →